PartnerFacts
Data last updated: Oct 23, 2026, 5:45 PM ETLatest filing: Oct 22, 2026Now: Oct 24, 2026, 5:14 AM ET

Sponsor Check › Person

PD
No photo found yet (own website and image search run after this page is viewed)

Punit Dhillon

Named as an officer, director or promoter on SEC Form D filings · CA · Jul 1, 2011 → Mar 27, 2024

4deals (issuers)
$70.6Mreported sold
65investors
16Form D filings
2011–2024years on file

Data last updated Oct 23, 2026, 5:45 PM ET · Courts (RECAP) last checked: Oct 24, 2026, 2:24 AM ET · SEC enforcement last checked: covered by the index scan as of Oct 24, 2026, 2:50 AM ET

The short version

Punit Dhillon is listed as an executive officer and director on 16 SEC Form D filings by 4 issuers between Jul 2011 and Mar 2024: Skye Bioscience, Inc. (San Diego, CA — biotechnology — 2018–2024; $62.3M reported sold to 43 investors), ONCOSEC MEDICAL Inc (Ewing, NJ — biotechnology — 2011–2017; $5.69M reported sold to 9 investors), Emerald Health Pharmaceuticals Inc. (San Diego, CA — pharmaceuticals — 2017–2021; $2.5M reported sold to 5 investors) and Emerald Health Bioceuticals Inc. (San Diego, CA — retailing — 2017–2020; $127K reported sold to 8 investors).

What this means A repeat sponsor — 4 separate companies raised money with this person listed as executive officer and director, over about 13 years. Across those companies the filings report $70.6M sold in total.

Listed alongside Avtar Dhillon (6 shared filings), James DeMesa (6 shared filings), Gaetano Morello (5 shared filings), Jim Heppell (5 shared filings), James L. Heppell (4 shared filings) and 30 others.

What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Punit. Each name links to their own page.

2 of the issuers belong to the sponsor group Emerald Health (3 issuers, $712K reported sold, 2017–2022).

What this means A sponsor group is one team that sets up a new company for each deal. Emerald Health has 3 companies on file and $712K reported sold in total — the group page shows the whole track record in one place.

Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — none found.

What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.

We compared 16 public filings for Punit Dhillon and found 11 differences: Form D filed 16 days after the first sale; Punit Dhillon's role changed at Skye Bioscience, Inc.: director → executive officer, director; and more below.

What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.

What the community is saying

Community search for Punit Dhillon has not run yet — it is joining a line of 10,676 names; searches run around the clock at the hosts' allowed rate. Searched so far: 27 names.

Community comments are quoted as written by their authors. Sources searched: BiggerPockets forums (via DuckDuckGo, Brave, Bing and BiggerPockets search) and Reddit (search feed + public archive).

Key records

Five things investors ask first. Items still in human review are counted, not shown.

1. Lawsuits

None found in sources searched — federal courts (CourtListener / RECAP), checked Oct 24, 2026

What was searched

Sources searched: CourtListener bulk data (RECAP dockets as of 2026-09-30; recall-first rule 10-24) — federal district + bankruptcy courts State courts: not covered (one-tap state court links under Look further). PACER: not searched. · Last checked Oct 24, 2026, 2:24 AM ET.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

2. Regulatory actions

None found in sources searched — SEC enforcement releases (index scan as of Oct 24, 2026, 2:50 AM ET) · state securities regulators: AZ, CA, DE, TX, WA (crawled Oct 23, 2026)

What was searched

SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — Searched SEC litigation releases and administrative proceedings (1995→ / 2007→) (30,205 records as of Oct 24, 2026, 2:50 AM ET) — nothing matched Punit Dhillon..

State securities regulators searched: AZ (Corporation Commission Securities Division), CA (DFPI — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first), DE (DOJ Investor Protection Unit), TX (State Securities Board), WA (DFI) — last crawled Oct 23, 2026, 9:57 PM ET. Other states are not covered.

3. Bankruptcies

None found in sources searched — federal bankruptcy courts (CourtListener / RECAP), checked Oct 24, 2026

What was searched

Sources searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not covered (one-tap state court links under Look further). PACER: not searched (RECAP only). · Last checked Oct 24, 2026, 2:24 AM ET.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

4. Differences between public sources

Comparisons cover issuers and sponsor groups — see the issuer pages under Deals

11 differences found between the filings for Punit Dhillon (compared 16 filings on Oct 24, 2026)

Note · Mar 3, 2020 – Mar 19, 2020

Form D filed 16 days after the first sale — Emerald Health Bioceuticals Inc.

The filing says the first sale was Mar 3, 2020. The Form D was filed Mar 19, 2020 — 16 days later. The rule: a Form D is generally due within 15 days after the first sale, so this one is 1 days past that.

What this means A late notice is common and carries no penalty by itself. It is worth asking the sponsor why the paperwork lagged.

Sources
Note · Nov 15, 2018 – Aug 29, 2023

Punit Dhillon's role changed at Skye Bioscience, Inc.: director → executive officer, director

The Nov 15, 2018 filing lists Punit Dhillon as director; the Aug 29, 2023 Form D lists executive officer, director.

What this means Roles on Form D are self-reported by the issuer. A change can mean a real change in who runs the company, or just a different box ticked. Ask who makes decisions today.

Sources
Note · Jan 25, 2018 – Feb 23, 2018

Offering amount changed between filings — Skye Bioscience, Inc.

The Jan 25, 2018 filing says $6,800,000 offered; the Feb 23, 2018 Form D/A says $8,570,000.

What this means The target raise changed. Raising the cap is common when a deal grows; ask whether the extra money has the same terms and use.

Sources
Note · Jul 27, 2017 – Aug 17, 2017

Offering amount changed between filings — Emerald Health Bioceuticals Inc.

The Jul 27, 2017 filing says $23,740 offered; the Aug 17, 2017 Form D/A says $127,006.

What this means The target raise changed. Raising the cap is common when a deal grows; ask whether the extra money has the same terms and use.

Sources
Note · Jan 18, 2018 – Jul 8, 2021

4 offerings have no amendment in the last 12 months and may still be open

No amendment in the last 12 months on an offering that may still be open — Emerald Health Pharmaceuticals Inc. (latest filing Jul 8, 2021) · No amendment in the last 12 months on an offering that may still be open — Emerald Health Bioceuticals Inc. (latest filing Mar 19, 2020) · No amendment in the last 12 months on an offering that may still be open — Skye Bioscience, Inc. (latest filing Nov 15, 2018) · No amendment in the last 12 months on an offering that may still be open — Skye Bioscience, Inc. (latest filing Feb 23, 2018)

What this means SEC rules expect a yearly amendment while an offering is still going. Ask the sponsor which of these raises have closed.

Sources
Note · Jul 1, 2011 – Jun 19, 2019

Punit Dhillon is written 2 different ways on the filings

listed as "Punit Dhillon" on 15 filings (from Jul 1, 2011), and "Punit S. Dhillon" on the Jun 19, 2019 filing.

What this means Same person, written differently — a middle name or suffix left off, or spelled another way. It is normal, but check that the full legal name matches your subscription documents.

Sources
Note · Jan 25, 2018 – Aug 29, 2023

Industry group changed between filings — Skye Bioscience, Inc.

"Pharmaceuticals" (Jan 25, 2018 to Nov 15, 2018); then "Biotechnology" (Aug 29, 2023 to Mar 27, 2024).

What this means The issuer described its business differently on different forms. Often it is just a different box ticked; sometimes the deal itself changed. Ask which business your money is in.

Sources
Note · Jul 27, 2017 – Mar 19, 2020

Industry group changed between filings — Emerald Health Bioceuticals Inc.

"Biotechnology" (Jul 27, 2017 to Aug 17, 2017); then "Retailing" (Mar 19, 2020).

What this means The issuer described its business differently on different forms. Often it is just a different box ticked; sometimes the deal itself changed. Ask which business your money is in.

Sources
Note · Jun 15, 2020 – Jul 19, 2022

Same name, different state: "Punit Dhillon" (MA) is a separate record

This page covers filings where the address state is CA. A separate record, "Punit Dhillon" with address state MA, is listed on 3 filings — most recently by Arch Therapeutics, Inc. (Jul 19, 2022). Both records have filings in the same period (Jun 15, 2020 to Jul 19, 2022).

What this means Two records with one name were active at the same time. That can be one person listing different company addresses, or two different people. We keep them apart until a filing ties them together. Check both pages before you decide.

Sources
Note · Nov 15, 2018 – Aug 29, 2023

Address moved from Long Beach, CA to San Diego, CA — Skye Bioscience, Inc.

The people listed on the Nov 15, 2018 filing give Long Beach, CA; on the Aug 29, 2023 filing they give San Diego, CA.

What this means Businesses move; this just shows the two places and dates. If you were told one city and the forms say another, ask which is current.

Sources
Note · Feb 23, 2018 – Nov 15, 2018

Address moved from Costa Mesa, CA to Long Beach, CA — Skye Bioscience, Inc.

The people listed on the Feb 23, 2018 filing give Costa Mesa, CA; on the Nov 15, 2018 filing they give Long Beach, CA.

What this means Businesses move; this just shows the two places and dates. If you were told one city and the forms say another, ask which is current.

Sources
What is compared

What is compared: every Form D and D/A we hold for this subject, side by side — filing dates vs. first-sale dates (the 15-day rule), amendment timing on open offerings (the yearly-amendment expectation), amounts sold, investor counts, offering amounts and minimums across amendments, industry and size bands, addresses, how each person's name and role is written, paid sellers' CRD numbers, and (for groups) where the member companies were formed and sit. Everything is as filed by the issuer; the SEC does not check it. Differences are common and usually have ordinary explanations — we show both values, the dates, and the source so you can ask. As of Oct 24, 2026.

5. Money to insiders

4 of 14 offerings report sales commissions totalling $6,367,184; 1 reports finder's fees totalling $180,000; 0 report proceeds to related persons. (includes amounts the issuer reported as estimates)

Offering (latest filing)Sales commissionsFinder's feesTo insidersPaid to sell itSource
Mar 27, 2024 D
Skye Bioscience, Inc.
File 021-508708
$2,400,000$0$0Piper Sandler & Co BrokerCheck CRD 665 ↗
Oppenheimer & Co. Inc. BrokerCheck CRD 249 ↗
EDGAR ↗
Feb 12, 2024 D
Skye Bioscience, Inc.
File 021-504974
$3,499,371$0$0Piper Sandler & Co BrokerCheck CRD 665 ↗
Oppenheimer & Co. Inc. BrokerCheck CRD 249 ↗
EDGAR ↗
Aug 29, 2023 D
Skye Bioscience, Inc.
File 021-490948
$0$0$0None listed on this filingEDGAR ↗
Jul 8, 2021 D
Emerald Health Pharmaceuticals Inc.
File 021-405544
$0$0$0None listed on this filingEDGAR ↗
Apr 19, 2021 D
Emerald Health Pharmaceuticals Inc.
File 021-396260
$0$0$0None listed on this filingEDGAR ↗
Mar 19, 2020 D
Emerald Health Bioceuticals Inc.
File 021-363301
$0$0$0None listed on this filingEDGAR ↗
Jun 19, 2019 D
Emerald Health Pharmaceuticals Inc.
File 021-342307
$0$0$0 (est.)None listed on this filingEDGAR ↗
Nov 15, 2018 D
Skye Bioscience, Inc.
File 021-325866
$0$0$0None listed on this filingEDGAR ↗
Feb 23, 2018 D/A
Skye Bioscience, Inc.
File 021-304091
$0$0$0None listed on this filingEDGAR ↗
Nov 28, 2017 D
ONCOSEC MEDICAL Inc
File 021-299625
$78,258$0$0H.C WAINWRIGHT & CO., LLC BrokerCheck CRD 375 ↗EDGAR ↗
Nov 2, 2017 D
ONCOSEC MEDICAL Inc
File 021-298011
$389,555$0$0
Any proceeds from the private placement will be used for working capital and general corporate purposes, which could include payments of salaries or other compensation to the Issuer's executive officers or directors.
H.C. Wainwright & Co., LLC BrokerCheck CRD 375 ↗EDGAR ↗
Aug 17, 2017 D/A
Emerald Health Bioceuticals Inc.
File 021-291607
$0$0$0None listed on this filingEDGAR ↗
Mar 14, 2017 D
Emerald Health Pharmaceuticals Inc.
File 021-282486
$0$0$0None listed on this filingEDGAR ↗
Jul 1, 2011 D
ONCOSEC MEDICAL Inc
File 021-162194
$0$180,000 (est.)$0 (est.)Rodman & Renshaw, LLC BrokerCheck CRD 16415 ↗
Roth Capital Partners, LLC BrokerCheck CRD 15407 ↗
EDGAR ↗
How this is counted

Counts come from Form D Items 12–15 on the filings in our index (latest filing per offering; one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.

Counted across every filing this person is listed on (latest filing per offering, per issuer).

Deals 4

Every issuer that named Punit Dhillon on a Form D, newest first. A Form D is the notice a company files after it starts selling a private investment.

Biotechnology

Skye Bioscience, Inc.

San Diego, CA · Jan 25, 2018 → Mar 27, 2024 · 6 filings
  • Mar 27, 2024 · D · $40,000,000 sold of $40,000,000 · 13 investors · min. No minimum reported · role: Executive Officer, Director (Chief Executive Officer, Chairman and Director) EDGAR ↗
  • Feb 12, 2024 · D · $49,991,010 sold of $49,991,010 · 11 investors · min. No minimum reported · role: Executive Officer, Director (Chief Executive Officer, Chairman and Director) EDGAR ↗
  • Aug 29, 2023 · D · $62,254,435 sold of $62,254,435 · 12 investors · min. No minimum reported · role: Executive Officer, Director (Chief Executive Officer, Chairman and Director) EDGAR ↗
  • Nov 15, 2018 · D · $2,000,000 sold of $32,500,000 · 1 investors · min. No minimum reported · role: Director EDGAR ↗
  • Feb 23, 2018 · D/A · $4,150,000 sold of $8,570,000 · 2 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jan 25, 2018 · D · $2,400,000 sold of $6,800,000 · 1 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $62.3M from 43 investors (100% of the $40M target) as of the latest filing. Punit is listed as executive officer, director on 6 filings for this deal.

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Pharmaceuticals · group: Emerald Health

Emerald Health Pharmaceuticals Inc.

San Diego, CA · Mar 14, 2017 → Jul 8, 2021 · 4 filings
  • Jul 8, 2021 · D · $300,000 sold of Indefinite · 1 investors · min. $100,000 · role: Director EDGAR ↗
  • Apr 19, 2021 · D · $500,000 sold of $500,000 · 1 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jun 19, 2019 · D · $2,500,000 sold of $2,500,000 · 1 investors · min. No minimum reported · role: Director EDGAR ↗
  • Mar 14, 2017 · D · $1,000 sold of $1,000 · 5 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $2.5M from 5 investors as of the latest filing. Punit is listed as director on 4 filings for this deal.

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pharmaceuticals / 506(b) (800 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Retailing · group: Emerald Health

Emerald Health Bioceuticals Inc.

San Diego, CA · Jul 27, 2017 → Mar 19, 2020 · 3 filings
  • Mar 19, 2020 · D · $52,000 sold of $5,000,000 · 5 investors · min. No minimum reported · role: Director (Chairman of the Board of Directors) EDGAR ↗
  • Aug 17, 2017 · D/A · $127,006 sold of $127,006 · 8 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jul 27, 2017 · D · $23,740 sold of $23,740 · 3 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $127K from 8 investors (3% of the $5M target) as of the latest filing. Punit is listed as director on 3 filings for this deal.

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Retailing / 506(b) (959 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Biotechnology

ONCOSEC MEDICAL Inc

Ewing, NJ · Jul 1, 2011 → Nov 28, 2017 · 3 filings
  • Nov 28, 2017 · D · $5,685,507 sold of $5,685,507 · 9 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
  • Nov 2, 2017 · D · $4,941,500 sold of $4,941,500 · 9 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
  • Jul 1, 2011 · D · $3,000,000 sold of $3,000,000 · 2 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗

Raised $5.69M from 9 investors (100% of the $5.69M target) as of the latest filing. Punit is listed as executive officer, director on 3 filings for this deal.

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Other pages with the same name (1)

Separate person records under the same name, not combined with this page. Each line says whether it shares an issuer with this record.

  • Punit Dhillon — MA, 1 issuer, Jun 15, 2020 → Jul 19, 2022 · no shared issuer

People around Punit 35

Officers, directors, promoters and management entities named on the same filings, as of Oct 23, 2026, 5:45 PM ET.

JD
No photo found yet (own website and image search run after this page is viewed)
Person

James DeMesa

Director, Executive Officer · 6 shared filings (2 issuers)

Listed on the same filings as Punit Dhillon. Their page shows their other deals.

AD
No photo found yet (own website and image search run after this page is viewed)
Person

Avtar Dhillon

Director, Executive Officer · 6 shared filings (3 issuers) · also on 2 other issuers

Avtar Dhillon is on 5 issuers in total — a repeat sponsor. Their page lists every one.

JH
No photo found yet (own website and image search run after this page is viewed)
Person

Jim Heppell

Director · 5 shared filings (3 issuers) · also on 6 other issuers

Jim Heppell is on 9 issuers in total — a repeat sponsor. Their page lists every one.

GM
No photo found yet (own website and image search run after this page is viewed)
Person

Gaetano Morello

Director, Executive Officer · 5 shared filings (2 issuers) · also on 1 other issuer

Listed on the same filings as Punit Dhillon. Their page shows their other deals.

JH
No photo found yet (own website and image search run after this page is viewed)
Person

James L. Heppell

Director · 4 shared filings (2 issuers)

Listed on the same filings as Punit Dhillon. Their page shows their other deals.

AS
No photo found yet (own website and image search run after this page is viewed)
Person

Andrew Schwab

Director · 3 shared filings (1 issuer) · also on 28 other issuers

Andrew Schwab is on 29 issuers in total — a repeat sponsor. Their page lists every one.

BM
No photo found yet (own website and image search run after this page is viewed)
Person

Brian S. Murphy

Executive Officer, Director · 3 shared filings (1 issuer) · also on 3 other issuers

Listed on the same filings as Punit Dhillon. Their page shows their other deals.

PG
No photo found yet (own website and image search run after this page is viewed)
Person

Paul Grayson

Director · 3 shared filings (1 issuer) · also on 6 other issuers

Paul Grayson is on 7 issuers in total — a repeat sponsor. Their page lists every one.

PT
No photo found yet (own website and image search run after this page is viewed)
Person

Praveen Tyle

Director · 3 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Punit Dhillon. Their page shows their other deals.

AM
No photo found yet (own website and image search run after this page is viewed)
Person

Anthony Maida

Director · 3 shared filings (1 issuer) · also on 2 other issuers

Listed on the same filings as Punit Dhillon. Their page shows their other deals.

JS
No photo found yet (own website and image search run after this page is viewed)
Person

Joachim Schupp

Executive Officer · 3 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Punit Dhillon. Their page shows their other deals.

AJ
No photo found yet (own website and image search run after this page is viewed)
Person

Annalisa Jenkins

Director · 3 shared filings (2 issuers) · also on 4 other issuers

Annalisa Jenkins is on 6 issuers in total — a repeat sponsor. Their page lists every one.

JB
No photo found yet (own website and image search run after this page is viewed)
Person

Jill Broadfoot

Executive Officer · 3 shared filings (2 issuers) · also on 1 other issuer

Listed on the same filings as Punit Dhillon. Their page shows their other deals.

LS
No photo found yet (own website and image search run after this page is viewed)
Person

Lisa Sanford

Executive Officer · 3 shared filings (1 issuer)

Listed on the same filings as Punit Dhillon. Their page shows their other deals.

AR
No photo found yet (own website and image search run after this page is viewed)
Person

Alain Rolland

Executive Officer · 3 shared filings (1 issuer)

Listed on the same filings as Punit Dhillon. Their page shows their other deals.

EM
No photo found yet (own website and image search run after this page is viewed)
Person

Eduardo Munoz

Executive Officer · 3 shared filings (1 issuer)

Listed on the same filings as Punit Dhillon. Their page shows their other deals.

DC
No photo found yet (own website and image search run after this page is viewed)
Person

Deborah Charych

Director · 3 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Punit Dhillon. Their page shows their other deals.

KA
No photo found yet (own website and image search run after this page is viewed)
Person

Kaitlyn Arsenault

Executive Officer · 3 shared filings (1 issuer)

Listed on the same filings as Punit Dhillon. Their page shows their other deals.

KW
No photo found yet (own website and image search run after this page is viewed)
Person

Keith Ward

Director · 3 shared filings (1 issuer)

Listed on the same filings as Punit Dhillon. Their page shows their other deals.

MD
No photo found yet (own website and image search run after this page is viewed)
Person

Margaret Dalesandro

Director · 3 shared filings (1 issuer)

Listed on the same filings as Punit Dhillon. Their page shows their other deals.

DC
No photo found yet (own website and image search run after this page is viewed)
Person

Daniel O'Connor

Executive Officer, Director · 2 shared filings (1 issuer) · also on 3 other issuers

Listed on the same filings as Punit Dhillon. Their page shows their other deals.

EB
No photo found yet (own website and image search run after this page is viewed)
Person

Elizabeth M. Berecz

Executive Officer · 2 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Punit Dhillon. Their page shows their other deals.

DD
No photo found yet (own website and image search run after this page is viewed)
Person

Dr. Avtar Dhillon

Executive Officer, Director · 2 shared filings (1 issuer)

Listed on the same filings as Punit Dhillon. Their page shows their other deals.

JB
No photo found yet (own website and image search run after this page is viewed)
Person

Jade Beutler

Executive Officer · 2 shared filings (1 issuer)

Listed on the same filings as Punit Dhillon. Their page shows their other deals.

DM
No photo found yet (own website and image search run after this page is viewed)
Person

Dr. Gaetano Morello

Director · 2 shared filings (1 issuer)

Listed on the same filings as Punit Dhillon. Their page shows their other deals.

RS
No photo found yet (own website and image search run after this page is viewed)
Person

Richard Slansky

Executive Officer · 2 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Punit Dhillon. Their page shows their other deals.

MC
No photo found yet (own website and image search run after this page is viewed)
Person

Michael Cross

Executive Officer · 1 shared filing (1 issuer)

Listed on the same filings as Punit Dhillon. Their page shows their other deals.

VV
No photo found yet (own website and image search run after this page is viewed)
Person

Veronica Vallejo

Executive Officer · 1 shared filing (1 issuer)

Listed on the same filings as Punit Dhillon. Their page shows their other deals.

JD
No photo found yet (own website and image search run after this page is viewed)
Person

Jim DeMesa

Executive Officer · 1 shared filing (1 issuer)

Listed on the same filings as Punit Dhillon. Their page shows their other deals.

DC
No photo found yet (own website and image search run after this page is viewed)
Person

Douglas A. Cesario

Executive Officer · 1 shared filing (1 issuer)

Listed on the same filings as Punit Dhillon. Their page shows their other deals.

JH
No photo found yet (own website and image search run after this page is viewed)
Person

James L. Hepell

Director · 1 shared filing (1 issuer)

Listed on the same filings as Punit Dhillon. Their page shows their other deals.

TD
No photo found yet (own website and image search run after this page is viewed)
Person

Tu Diep

Executive Officer · 1 shared filing (1 issuer)

Listed on the same filings as Punit Dhillon. Their page shows their other deals.

MD
No photo found yet (own website and image search run after this page is viewed)
Person

Margaret Dalesamdro

Director · 1 shared filing (1 issuer)

Listed on the same filings as Punit Dhillon. Their page shows their other deals.

ET
No photo found yet (own website and image search run after this page is viewed)
Person

Elena Traistaru

Executive Officer · 1 shared filing (1 issuer)

Listed on the same filings as Punit Dhillon. Their page shows their other deals.

NC
No photo found yet (own website and image search run after this page is viewed)
Person

Nancy Coulson

Executive Officer · 1 shared filing (1 issuer)

Listed on the same filings as Punit Dhillon. Their page shows their other deals.

The team behind the deals

Sponsor group

Emerald Health

3 issuers · 13 filings · $712K reported sold · 2017–2022

One team, 3 deal companies. Punit Dhillon is listed on 2 of them.

Sources

Issuers are grouped when their Form D filings share related persons, a management entity or a business address (automatic match from the filings). "Listed" marks the issuers that name Punit Dhillon.

Registrations and other filings

Adviser registration (Form ADV)

None of the 4 issuers this person is listed on appears in Form ADV (searched 24,962 advisers as of Oct 2, 2026). A person is never an adviser firm; Form ADV is checked for the issuers and the management companies they are listed with.

Other offering types (Regulation A and Regulation Crowdfunding)

Searched SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 (51,358 records as of Oct 23, 2026, 8:41 PM ET) — nothing matched this name.

Property records none — individuals are not matched

Property records are matched to companies only, never to individuals, so none are matched to Punit Dhillon by design. Searched property records in Hillsborough County FL (Clerk recorded-document index Oct 14, 2026 to Oct 15, 2026 + FL DOR 2026 ownership roll), Miami-Dade County FL (FL DOR 2026 ownership roll), Harris County TX (HCAD 2026 ownership roll), Dallas County TX (DCAD 2026 ownership roll), New York City ACRIS documents and PLUTO ownership rows already retrieved for other issuers, Cook County IL sale and ownership rows already retrieved for other issuers (814,874 records as of Oct 23, 2026, 8:59 PM ET) for the 4 issuers this person is listed on — nothing matched.

Public profiles and social

Websites and social links of the issuers Punit Dhillon is listed on: none on file. No website or social profile named in ONCOSEC MEDICAL Inc's SEC filings (Form C, Reg A, Form ADV; checked Oct 24, 2026). Web search for this name: #125,828 of 374,652 in line (14 issuers searched so far). One-tap searches: Look further ↓

Look further

One-tap searches on sites we do not index ourselves, with the name pre-filled (Ewing, NJ). Each opens in a new tab; what you find there is not verified by PartnerFacts.

Change history

No corrections have been requested for this page.

Every fact links to its public-record source. Plain-English notes next to a fact are our reading of that fact, not a rating. Request a correction · Facts policy

Request a correction

Free. Logged with status: received → under review → fixed / confirmed with source.

Add a response

If this is you or your firm, add a sourced explanation next to any fact. Reviewed before publishing.

Monitor this person

Members get an email when Punit Dhillon appears on a new Form D, or when a court case or SEC action is matched to them. See plans →